Kiel Iwanik

Kiel Iwanik has a diverse work experience in various industries. Kiel currently works as an Associate Director of Business Development at Astria Therapeutics, Inc. starting from May 2023. Prior to this, they worked at EQRx as a Senior Manager of Business Development. During their time at EQRx, they were responsible for seeking partnerships and leading due diligence efforts for the company's pipeline of oncology and immunology drugs. Before that, they worked at Karner Blue Capital, LLC in the field of Sustainable Investments and Strategy from November 2017 to January 2020. Kiel also gained experience as a Fund Manager at BR Venture Fund, where they sourced deals and conducted due diligence on prospective portfolio companies. Kiel furthered their expertise in ESG Investment Research as an MBA Intern at Calvert Investments, where they performed screening, analyzed water risk, and developed investor recommendations. Earlier in their career, Kiel worked at Foundation Medicine as a Supervisor of DNA & RNA Extraction and as a Clinical Lab Technologist III. In these roles, they implemented process improvements, hired and trained staff, and performed technical assays in a high-throughput lab. Their career began at Genzyme, where they worked as a Molecular Genetics Technologist I and as a Molecular Genetics Technician, performing genetic sequencing and interpreting results.

Kiel Iwanik has a Bachelor of Science degree in Biology from the University of Massachusetts Amherst. In addition, Kiel Iwanik has pursued further education at the Cornell Johnson Graduate School of Management, where they completed a Master of Business Administration (MBA) with a specialization in Sustainable Global Enterprise. The specific start and end years for both degrees are not provided.